121 related articles for article (PubMed ID: 6212270)
21. Adverse effects related to thionamide drugs and their dose regimen.
Werner MC; Romaldini JH; Bromberg N; Werner RS; Farah CS
Am J Med Sci; 1989 Apr; 297(4):216-9. PubMed ID: 2523194
[TBL] [Abstract][Full Text] [Related]
22. [Syndrome of arthritis by antithyroid drugs].
Martín Marco A; Boquet Estruch D
Med Clin (Barc); 2003 Mar; 120(11):436-7. PubMed ID: 12681226
[No Abstract] [Full Text] [Related]
23. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
[TBL] [Abstract][Full Text] [Related]
24. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
Macia M; Méndez M; Fernández J; Riverol A; Rios
Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
[No Abstract] [Full Text] [Related]
25. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
26. Lupus-like syndrome--a rare complication in thionamide treatment for Graves' disease.
Takuwa N; Kojima I; Ogata E
Endocrinol Jpn; 1981 Oct; 28(5):663-7. PubMed ID: 6896490
[TBL] [Abstract][Full Text] [Related]
27. [Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].
Nakashima T
Rinsho Byori; 1982 Feb; 30(2):170-8. PubMed ID: 6177885
[No Abstract] [Full Text] [Related]
28. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
Rivkees SA; Szarfman A
J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
[TBL] [Abstract][Full Text] [Related]
29. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
30. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
[TBL] [Abstract][Full Text] [Related]
31. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
32. Antithyroid drugs.
Cooper DS
N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
[No Abstract] [Full Text] [Related]
33. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
34. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
35. Hepatotoxicity from antithyroid drugs.
Vitug AC; Goldman JM
Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
[TBL] [Abstract][Full Text] [Related]
36. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
Shiroozu A; Taurog A; Engler H; Dorris ML
Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
[TBL] [Abstract][Full Text] [Related]
39. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É
Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
[TBL] [Abstract][Full Text] [Related]
40. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
Bahn RS; Burch HS; Cooper DS; Garber JR; Greenlee CM; Klein IL; Laurberg P; McDougall IR; Rivkees SA; Ross D; Sosa JA; Stan MN
Thyroid; 2009 Jul; 19(7):673-4. PubMed ID: 19583480
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
